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Abstract. The ERM proteins, ezrin, radixin, and 
moesin, are involved in the actin filament/plasma mem- 
brane interaction as cross-linkers. CD44 has been iden- 
tified as one of the major membrane binding partners 
for ERM proteins. To examine the CD44/ERM protein 
interaction in vitro, we produced mouse ezrin, radixin, 
moesin, and the glutathione-S-transferase (GST)/CD44 
cytoplasmic domain fusion protein (GST-CD44cyt) by 
means of recombinant baculovirus infection, and con- 
structed an in vitro assay for the binding between ERM 
proteins and the cytoplasmic domain of CD44. In this 
system, ERM proteins bound to GST-CD44cyt with 
high affinity (K  s of moesin was 9.3 _+ 1.6nM) at a low 
ionic strength, but with low affinity at a physiological 
ionic strength. However, in the presence of phospho- 
inositides (phosphatidylinositol [PI], phosphatidylinosi- 
tol 4-monophosphate [4-PIP], and phosphatidylinositol 
4,5-bisphosphate [4,5-PIP2]),  ERM proteins bound with 
a relatively high affinity to GST-CD44cyt even at a 
physiological ionic strength : 4,5-PIP  2 showed a marked 
effect (Kd of moesin in the presence of 4,5-PIPE was 
9.3 _+ 4.8 nM). Next, to examine the regulation mecha- 
nism of CD44/ERM interaction in vivo, we reexamined 
the immunoprecipitated CD44/ERM complex from 
BHK cells and found that it contains Rho-GDP dissoci- 
ation inhibitor (GDI), a regulator of Rho GTPase. We 
then evaluated the involvement of Rho in the regula- 
tion of the CD44/ERM complex formation. When re- 
combinant ERM proteins were added and incubated 
with lysates of cultured BHK cells followed by centrifu- 
gation, a portion of the recombinant ERM proteins was 
recovered in the insoluble fraction. This binding was 
enhanced by GTP~S and markedly suppressed by C3 
toxin, a specific inhibitor of Rho, indicating that the 
GTP form of Rho in the lysate is required for this bind- 
ing. A mAb specific for the cytoplasmic domain of 
CD44 also markedly suppressed this binding, identify- 
ing most of the binding partners for exogenous ERM 
proteins in the insoluble fraction as CD44. Consistent 
with this binding analysis, in living BHK cells treated 
with C3 toxin, most insoluble ERM proteins moved to 
soluble compartments in the cytoplasm, leaving CD44 
free from ERM. These findings indicate that Rho regu- 
lates the CD44/ERM complex formation in vivo and 
that the phosphatidylinositol turnover may be involved 
in this regulation mechanism. 
!  r'~IRM  (Ezrin/Radixin/Moesin)  family  proteins  are 
F'~I  thought  to  function  as  general  cross-linkers  be- 
tween  plasma  membranes  and  actin  fdaments 
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1. Abbreviations used in this paper: C-moesin and N-moesin, carboxyl-ter- 
minal half and amino-terminal half of recombinant moesin; ERM, ezrin/ 
(Bretscher,  1983; Pakkanen  et  al.,  ]987;  Lankes  et  al., 
1988; Sa. Tsukita et al., 1989; Algrain et al., 1993; Arpin et 
al.,  1994). The  ERM family consists of three  closely re- 
lated proteins, ezrin, radixin,  and moesin (Sato et al., 1992; 
radixin/moesin; GDI, GDP dissociation inhibitor; GDS, GDP dissociation 
stimulator;  GST,  glutathione-S-transferase; PC,  phosphatidylcholine; 
PI,  phosphatidylinositol; 4-PIP,  phosphatidylinositol 4-monophosphate; 
PIP2, phosphatidylinositol 4,5-bisphosphate. 
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cells, they are expressed and localized at specialized re- 
gions where  actin  filaments  are  densely associated with 
plasma membranes, such as cleavage furrows, microvilli, 
ruffling  membranes,  and  cell--cell/cell-matrix  adhesion 
sites (especially at primordial forms of cadherin- and inte- 
grin-based  cell  adhesion  sites),  whereas  among  organs 
their expression varies, suggesting some dedifferentiation 
in terms of ERM expression in cultured cells (Bretscher, 
1983; Pakkanen et al.,  1987; Lankes et al.,  1988; Sa. Tsu- 
kita et al., 1989; Sato et al.,  1991,1992;  Sh. Tsukita et al., 
1992; Berryman et al., 1993; Franck et al., 1993; Amieva et 
al., 1994; Takeuchi et al., 1994b; Henry et al., 1995). The 
suppression of ERM expression with antisense oligonucle- 
otides destroys microvilli, cell-cell, and cell-matrix adhe- 
sion sites (Takeuchi et al., 1994b), and the introduction of 
a dominant-negative construct of ezrin and radixin impairs 
the  cortical  actin  organization  and  cytokinesis,  respec- 
tively (Henry et al., 1995; Martin et al., 1995). 
Sequencing has revealed that the three ERM proteins 
are highly homologous; in the mouse, the identity is 75, 72, 
and 80% for ezrin/radixin, ezrin/moesin, and radixin/moesin, 
respectively  (Gould  et  al.,  1989;  Turunen  et  al.,  1989; 
Funayama et al., 1991; Lankes and Furthmayr, 1991; Sato 
et al., 1992). The sequences of their amino-terminal halves 
are highly conserved (~85% identity for any pair). A  tu- 
mor suppresser molecule responsible for neurofibromato- 
sis  type 2,  named merlin or schwannomin, was  recently 
identified,  which  has  significant  sequence  similarity  to 
ERM  proteins:  ,-o49%  identity  overall  and,  especially, 
~85% identity in their amino-terminal halves (Rouleau et 
al., 1993; Trofatter et al., 1993). 
The highly conserved amino-terminal sequence in ERM 
proteins is also found in the amino-terminal end of some 
membrane-associated proteins such  as band  4.1  protein, 
talin, PTPH1, and PTPMEG, indicating a band 4.1 super- 
family (Conboy et al.,  1986;  Rees et al.,  1990;  Gu et al., 
1991; Yang and Tonks, 1991; Arpin et al., 1994; Takeuchi 
et al., 1994a). Considering that this conserved domain in 
band 4.1 protein is reportedly responsible for its direct as- 
sociation with glycophorin C, an integral membrane glyco- 
protein  of erythrocyte membranes  (Bennett,  1989),  the 
amino-terminal half domain of ERM proteins was thought 
to directly bind to some integral membrane proteins. Im- 
munoprecipitation experiments using cultured cells subse- 
quently  revealed  that  CD44  is  directly  associated  with 
ERM proteins (Tsukita et al., 1994).  CD44 is a polymor- 
phic cell-surface glycoprotein which is found on a wide va- 
riety of cells (Haynes et al., 1989, 1991; Lesley et al., 1993) 
that is also called Pgp-1 (Zhou et al., 1989), HCAM (Gold- 
stein et al., 1989), Hermes antigen (Jalkanen et al., 1986), 
and  ECMRIII  (Wayner et  al.,  1988).  In  cultured fibro- 
blasts, CD44 is precisely colocalized with ERM proteins, 
favoring  the  notion  that  CD44  is  a  membrane  binding 
partner of ERM proteins (Tsukita et al.,  1994).  However, 
in the body, the expression of CD44 varies among tissues 
and its distribution is not necessarily identical to that of 
ERM  proteins  (Berryman et al.,  1993; Nakamura  et al., 
1996). Furthermore, in some types of cells, integral mem- 
brane  proteins  such  as  CD43  and  the  H+/K  +  ATPase 
pump are precisely colocalized with ERM proteins (Han- 
zel  et  al.,  1991;  Yonemura et al.,  1993). These findings 
suggest that ERM proteins bind to a specific group of inte- 
gral  membrane  proteins,  including  CD44.  Considering 
that  CD44  is  rather  highly  and  ubiquitously  expressed, 
however, it could be a major binding partner of ERM pro- 
teins. 
The carboxyl-terminal half of ERM proteins, especially 
the carboxy-terminal 34 amino acids, interacts with actin 
filaments (Turunen et al., 1994; Pestonjamasp et al., 1995). 
The coexistence of plasma membrane- and actin filament- 
binding domains in individual molecules allows ERM pro- 
teins  to  function  as  a  plasma  membrane/actin  filament 
cross-linker. Considering that the plasma membrane/actin 
filament  association  is  dynamically  regulated,  the  next 
question is how the membrane binding of ERM proteins is 
regulated in vivo. 
In this study, we first analyzed the manner of binding 
between  ERM  proteins  and  the  cytoplasmic domain  of 
CD44 in vitro using recombinant ERM and a glutathione- 
S-transferase  (GST)/CD44  cytoplasmic  domain  fusion 
protein produced by means of recombinant baculovirus in- 
fection.  We  found  that  the  CD44  cytoplasmic  domain 
showed very weak binding activity to any of the ERM pro- 
teins at physiological ionic strength, but that in the pres- 
ence of phosphatidylinositol 4,5-bisphosphate  (4,5-PIP2), 
it bound with high  affinity to ERM  proteins  (the Kd of 
moesin was 9.3 +__ 4.8 nM). These findings are not only the 
first to show that ERM proteins can bind to the cytoplas- 
mic domain of CD44 in vitro, but also suggests that the 
formation of CD44/ERM  complex is  dynamically regu- 
lated in vivo. Next, we reexamined the CD44/moesin im- 
mune complex from BHK cells and found that Rho-GDP 
dissociation inhibitor (GDI), a regulator of a small GTP- 
binding protein Rho, was tightly associated with the CD44/ 
moesin complex. 
Rho  reportedly  regulates  the  actin  filament-plasma 
membrane association (Hall, 1990; Ridley and Hall, 1992; 
Ridley et al., 1992; Takai et al., 1995; Zigmond, 1995). The 
Rho family belongs to the small GTP-binding protein su- 
perfamily and consists of the Rho, Rac, and Cdc42 sub- 
families.  Interconversion  between  active  and  inactive 
forms (GTP-Rho and GDP-Rho, respectively) is regulated 
by guanine nucleotide exchange factors (GEFs) and GTP- 
ase-activating proteins (GAPs). Rho-GDI, Smg-GDP dis- 
sociation stimulator (GDS), Dbl, and Ost have been iden- 
tified as GEFs. Therefore, the occurrence of Rho-GDI in 
the CD44/ERM  complex suggests that this complex for- 
mation is regulated by Rho. We then established  a  cell- 
free system with which to measure the binding of the exog- 
enous recombinant ERM proteins to the insoluble fraction 
of the lysate of BHK cells, and we found that the binding 
of ERM proteins to the cytoplasmic domain of CD44 was 
enhanced  by GTP-/S and  remarkably suppressed  by C3 
toxin, a specific inhibitor of Rho GTPase (Aktories et al., 
1988; Kikuchi et al., 1988; Narumiya et al., 1988; Braun et 
al., 1989).  In good agreement with these binding results, 
when living BHK cells were incubated with C3 toxin, most 
insoluble ERM  proteins moved to the  soluble compart- 
ments in the cytoplasm, leaving free CD44. We thus con- 
cluded that Rho regulates the formation of CD44/ERM 
complex in vivo and that the elevation of 4,5-PIP2 concen- 
tration in plasma membranes is possibly involved in this 
regulation pathway. 
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Cells and Antibodies 
Sf9 and High Five cells were purchased from InVitrogen (San Diego, CA) 
and cultured in TC-100  medium (GIBCO BRL, Gaithersburg, MD) sup- 
plemented with tryptose phosphate broth (GIBCO BRL) and 10%  FCS 
at 27oc.  BHK cells were cultured in DME supplemented with 5% new- 
born calf serum and 10% tryptose phosphate broth. The mAbs, Mll, R2-1, 
and M22, were raised in rats against recombinant mouse ezrin, radixin, 
and moesin, respectively  (Takeuchi et al., 1994b). The pAbs, I1 and p-800, 
were raised in rabbits against purified rat radixin and recombinant mouse 
radixin,  respectively (Sa. Tsukita et al., 1989; Funayama et al., 1991). The 
pAb I1 was used to detect all ERM proteins by immunoblotting (Sa. Tsu- 
kita et al.,  1989; Sato et al., 1992). The mouse mAb CR-22 reacts specifi- 
cally with moesin in immunoprecipitation (Sato et al., 1992; Tsukita et al., 
1994). Anti-mouse rho-GDI mAb has been characterized (Shimizu et al., 
1991 ). The rat mAb30189 is specific for hamster CD44 (Tsukita et al., 1994). 
Monoclonal antibodies were produced in the rat using the GST fusion 
protein with the cytoplasmic domain of mouse CD44 (GST-CD44cyt) as 
described (Sh. Tsukita et al., 1989). The culture supernatant of each hybri- 
doma was screened to select  mAbs that recognize not only mouse CD44 
(GST-CD44cyt and in mouse MTD-IA cells)  but also hamster CD44 (in 
BHK cells) by immunoblotting. 
Production and Purification of Recombinant Ezrin, 
Radixin, and Moesin 
Mouse ezrin,  radixin,  or moesin full-length  cDNA was integrated into the 
baculovirus genome, and the recombinant virus containing ezrin,  radixin, 
or moesin cDNA was isolated and condensed using a  MAXBAC  TM  kit 
(InVitrogen). Insect Sf9 cells were infected with recombinant viruses, cul- 
tured in 200 ml spinner flasks at 27°C for 72 h, and then washed with PBS. 
After being suspended in PBS (3 ×  106 cells/ml)  containing 2 mM EGTA, 
2 mM PMSF and 4 ~g/ml of leupeptin, the cells were homogenized in a 
tight-fitting  Dounce homogenizer and sonicated, followed by centrifuga- 
tion at 100,000 g for 1 h at 4°C. 
The supernatant was applied to a heparin column (5 ml in 15 × 25 mm; 
Hi TrapHeparin; Pharmacia LKB Biotechnology AB, Uppsala, Sweden) 
equilibrated with DG buffer (10 mM Hepes, pH 7.5,  1 mM EGTA, 0.1 
mM DTT). After thoroughly washing with DG containing 150 mM KCI, 
proteins were eluted with a linear concentration gradient of KCI (150-750 
mM). Recombinant ERM proteins were eluted around 350 mM KCI. The 
eluate was dialyzed  against DG followed by centrifugation at 100,000 g for 
1 h. The supernatant was loaded onto a Q-Sepharose column (1 ml in 8 × 
38 mm; Econo-PacQ; Bio-Rad Laboratories, Hercules, CA) equilibrated 
with DG. The column was washed with DG and then proteins were eluted 
with a linear concentration gradient of KC1 (0-200 mM). Purified  ERM 
proteins were eluted around 50 mM KCI. The purity of each protein was 
determined by SDS-PAGE (see Fig. 1). 
Production and Purification of GST-Fusion Protein 
with the Cytoplasmic Domain of CD44 
The cDNA encoding the full-length  of the cytoplasmic domain of mouse 
CD44 (1180-1395  bp: CD44cyt)  with BamHI and EcoRI sites at the ends 
was produced by PCR using mouse lung cDNA library as the template, 
and  subcloned into pBluescript SK(-). The insert was then subcloned 
into the pGEX2T expression vector, which was designed to express a GST 
fusion protein  in  Escherichia  coli.  Using this GST-CD44cyt  expression 
vector as a template, the GST-CD44cyt cDNA with NheI and Bglll sites 
at the ends was produced by PCR and then subcloned into pBluescript 
SK(-). The insert was integrated into the baculovirus genome, and the re- 
combinant virus containing OST-CD44cyt cDNA was isolated and con- 
densed using a  MAXBAC  TM  kit  (InVitrogen). The correct sequence of 
the PCR products was confirmed by sequencing with a Taq terminator cy- 
cle sequencing kit (DyeDeoxyVM;  Applied Biosystems, Inc., Foster City, CA). 
Insect Sf9 cells were infected~ cultured, washed, homogenized, and cen- 
trifuged  as  described  above.  The  supernatant was incubated  with glu- 
tathione-Sepharose  4B  beads  (Pharmacia  LKB  Biotechnology  AB), 
which had been washed with PBS for 30 rain at room temperature. The 
glutathione-Sepharose beads bound to GST-CD44cyt were washed with 
W buffer (10 mM Hepes, pH 7.5, 2 mM PMSF,  4 ~tg/ml leupeptin) and 
used in the in vitro binding assay.  In some experiments, GST-CD44cyt 
was purified by elution with H buffer containing 30 mM glutathione, dia- 
lyzed  against H buffer, and then used for the in vitro binding assay.  The 
control experiments included  GST expressed in E.  coli  using pGEX2T 
and purified using glutathione-Sepharose 4B beads. 
Production and Purification of the Amino- and 
Carboxyl-terminal Halves of  Moesin 
The cDNAs encoding the amino-terminal (1-930 bp) and carboxyl-termi- 
nal halves (931-1733  bp) of mouse moesin were produced by PCR using 
the moesin cDNA clone p22T6 (Sato et al., 1992) as the template and sub- 
cloned into pBluescript SK(-). These inserts were integrated into the bac- 
ulovirus genome, and the recombinant virus containing the cDNA encod- 
ing  the  amino-  or  carboxyl-terminal  half of moesin  was isolated  and 
condensed using a MAXBAC  TM kit (InVitrogen). The sequences of the 
PCR products were confirmed using a Taq terminator cycle sequencing 
kit (DyeDeoxyTM; Applied Biosystems Inc.). 
To obtain a large amount of the amino-terminal half of recombinant 
moesin (N-moesin), we used insect High Five (HF) cells  instead of Sf9 
cells.  HF cells  were infected  with recombinant virus carrying N-moesin 
cDNA, cultured on 19-cm dishes at 27°C for 48 h, and then washed with 
PBS.  After being suspended in low salt buffer (2 mM Tris-HCl, pH 10, 
1 mM EGTA, 0.5 mM PMSF), the cells were sonicated and centrifuged at 
100,000 g for 10 min at 4°C. The pellet was resuspended and sonicated in 
TE (10 mM Tris-HCL pH 8.0, 0.1 mM EDTA) containing 1% Triton X-100 
followed by a 60 min incubation at 4°C. The sonicate was centrifuged at 
100,000 g for 1 h, and the supernatant was dialyzed  against DG. The dialy- 
sate was applied onto a heparin column (5 ml in 15 × 25 ram; HiTrap He- 
parin)  that  had  been  equilibrated  with DG.  After thoroughly washing 
with DG, proteins were eluted with a linear concentration gradient of KCI 
(0-800 raM).  Recombinant N-moesin was eluted at around 600 mM KCI. 
To produce the carboxyl-terminal half of moesin (C-moesin), Sf9 cells 
were infected with recombinant viruses containing  C-moesin cDNA. C-moe- 
sin was purified in the same manner as the full-length  moesin. 
In Vitro Binding Assay between ERM Proteins and 
CD44 Using GST-CD44cyt Beads 
After the glutathione-Sepharose beads containing GST-CD44cyt fusion 
protein  or  GST  were  pretreated  with  RIPA  buffer (0.1%  SDS,  0.5% 
deoxycholic  acid,  1%  Nonidet  P-40,  50 mM Tris-HCl, pH 8.0, 150 mM 
NaCl) for 20 rain at room temperature, they were washed with 20 vol of H 
buffer (10 mM Hepes, pH 7.5, 1 mM MgCl2). After a brief centrifugation, 
30 pA of the glutathione-conjugated Sepharose bead slurry was suspended 
in 200 ~l of H buffer containing 40 mM or 150 mM KCI. In some experi- 
ments, 150 mM KCI H buffer contained 50 l-zg/ml phosphatidylserine (PS), 
phosphatidylcholine (PC), phosphatidylinositol (PI), phosphatidylinositol 
4-phosphate (4-PIP), or 4,5-PIP 2 (Sigma Chemical  Co.,  St.  Louis, MO). 
Each phospholipid was dissolved in distilled  water to a final concentration 
of 1 mg/ml and sonicated three times each for 10 s. 
Bead suspension (230 ~tl) was incubated with 4/,zg of purified ezrin, ra- 
dixin, moesin, N-moesin, or C-moesin in 10-20 pA of 40 or 150 mM KCI H 
buffer for 30  min at  room temperature. The beads were washed three 
times with H  buffer by a brief centrifugation, and bound proteins were 
eluted from the beads with H buffer containing 30 mM glutathione. The 
amount of GST-CD44cyt or GST in each eluate was determined by SDS- 
PAGE, An appropriate amount of each eluate was again applied to SDS- 
PAGE  to contain the same amount of GST-CD44cyt  or GST, and  the 
amount of ezrin,  radixin,  moesin, N-moesin, or C-moesin in each eluate 
was evaluated by immunoblotting with specific mAbs. 
Estimation of the Dissociation Constant between 
Moesin and CD44cyt 
To estimate the dissociation constant between CD44cyt  and moesin, 30 ~l 
of  the  glutathione-Sepharose  bead  slurry  containing  40  l,  zg  of  GST- 
CD44cyt  was incubated in 240 ~l of 40 or 150 mM KCI H buffer contain- 
ing 0-100 pmol (0-13.3  p,g) of purified moesin in the presence or absence 
of 4,5-PIP 2.  After  the  beads  were  washed  three  times  with  H  buffer, 
bound moesin was eluted  with H  buffer containing 30 mM glutathione. 
The amount of moesin in each eluate was estimated by comparing the sil- 
ver staining intensity of moesin band with that of various amounts of au- 
thentic purified moesin resolved and silver  stained in the same gel. The 
staining intensity was measured by a  densitometer using Adobe Photo- 
shop TM 3.0J histogram and a Scatchard plot of the data was generated. 
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constant. 
In Vitro Binding between ERM Proteins and CD44 
Using Ezrin/Radixin-coupled  Beads 
Purified  ezrin (10 ~g) was coupled to 30 ixl of Affigel-10  (Bio-Rad Labo- 
ratories). These ezrin-coupled beads were incubated with 1% BSA at 4°C 
for 2 h followed by 1 mg/ml GST in H buffer containing 150 mM KC1 at 
4°C overnight and then suspended in 200 ill of H  buffer containing 150 
mM KC1 in the presence or absence of 50 Ixg/ml  PS, PC, PI, 4-PIP or 4,5-PIP2. 
They were then incubated with 5 Ixg purified GST-CD44cyt in 40 p,1 of 150 
mM KC1 H buffer for 30 rain at room temperature. In the control experi- 
ment, the GST-fusion protein with the cytoplasmic domain of E-cadherin 
was used instead of the GST-CD44cyt.  After washing three times with the 
incubation solution, bound proteins were eluted from beads with the sam- 
ple buffer for SDS-PAGE. Each eluate was resolved by electrophoresis 
and stained with Coomassie brilliant blue. 
In some experiments, 20 p,g of ezrin or radixin was coupled to 50 Ixl of 
CNBr-activated  Sepharose (Pharmacia LKB Biotechnology AB). These 
beads were blocked only by 1%  BSA at 4°C for 2 b, and 50 Ixl of beads 
were suspended in 200 txl of 150 mM KC1 H buffer in the presence or ab- 
sence of 50 ixg/ml 4,5-PIP2. They were then incubated with GST-CD44cyt, 
and the amount of bound GST-CD44cyt was determined according to the 
same procedure as that  used with ERM-coupled  Affigel  beads, except 
that purified GST was used as a control and that bound GST-CD44cyt was 
detected by immunoblotting with anti-GST pAb. 
Gel Filtration  Chromatography 
Gel filtration was performed on Superose 12R  10/30 (24 ml; 1 ×  30 cm; 
equilibrated with DG) at 4°C. Each ERM protein or GST-CD44cyt (6 p,g) 
was mixed with no phospholipid, PS, PC, PI, 4-PIP, or 4,5-PIP z (20 Ixg) in 
~200 ~1 of 10 mM Hepes, pH 7,5, containing 1 mM MgCI2 and 150 mM 
KCI and then passed through the column. Eluted proteins were detected 
by ELISA using anti-ERM protein pAb, I1, or anti-GST pAb. 
Immunoprecipitation 
BHK cells were cultured as monolayers in 100-mm-diam plastic dishes to 
80-90%  confluence.  After washing once with methionine-free medium 
supplemented with 2% fetal calf serum, the monolayers were incubated 
with 3 ml of the same medium containing 0.2 mCi[35S]methionine  (Amer- 
sham International plc., Buckinghamshire, U.K.) for 3 h and washed three 
times with PBS. The labeled cells on one dish were lysed and incubated in 
0.4-0.8  ml of RIPA buffer (0.1%  SDS, 0.5%  deoxycholate, 1% Nonidet 
P-40, 150 mM NaCl, 50 mM Tris, pH 8.0, 1 mM p-amidinoPMSF, and 10 
~g/ml leupeptin) for 5 rain. The RIPA lysate was removed from the dish 
after fully dislodging  any remaining cellular  debris with a rubber police- 
man. After centrifugation at 12,000 g for 15 min, the RIPA-soluble super- 
natant was immunoprecipitated with 15  Ixl of protein G-Sepharose 4B 
(Zymed Laboratories, Inc.,  South San Francisco, CA) conjugated  with 
anti-moesin mAb CR-22  or control mouse IgG. In some experiments, to 
chase the labeled rnoesin, 100 Ixl of 0.05 mg/ml purified nonlabeled recom- 
binant moesin in 50 mM KCI/10 mM Hepes, pH 7.5, was added to 300 Ixl 
of the RIPA lysate of [35S]methionine-labeled  BHK cells. Sepharose 4B- 
bound immune complexes were washed five times with RIPA buffer. Im- 
mune complexes were then eluted by boiling in sample buffer that did not 
contain  2-rnercaptoethanol  and  resolved by  SDS-PAGE.  The  [35S]me- 
thionine signal was quantified by means of a Fujix Bioimage Analyzer Bas 
2000 System (Fuji Film Co., Tokyo, Japan). 
For reimmunoprecipitation, the immune complexes were eluted from 
15 ~l of Sepharose 4B into 1.5-ml test tubes with 50 t~l of a high salt solu- 
tion consisting of 0.98 M KCI, 0,02 M NaC1, 1 mM MgCle, 10 mM MOPS, 
pH 7.4. The eluates from five tubes were combined and diluted with 6 vol 
of distilled  water and then reirnmunoprecipitated with 20 p~l of protein 
G-Sepharose 4B  conjugated with mouse anti-rho-GDI mAb or control 
mouse IgG. After five washes with the high salt solution diluted  with 6 vol 
of distilled  water, immune complexes were eluted  and  analyzed  as de- 
scribed above. 
In Vitro Translation of Mouse Rho-GDI 
Translation in vitro proceeded as reported (Pelham and Jackson, 1976). 
RNA was synthesized from the full-length  cDNA of rho-GDl that was 
subcloned into the KpnI-digested  Bluescript SK(-) vector using an mCAP  TM 
mRNA Capping Kit (Stratagene, La Jolla,  CA). Capped RNA was trans- 
lated  in mRNA-dependent rabbit reticulocyte lysate  in the presence of 
[35S]methionine using an In  Vitro Express  TM Translation kit (Stratagene). 
The [35S]methionine (1,300 Ci/mmol, Amersham International plc.) radio- 
chemical concentration was 2.6 mCi/ml in a final reaction volume of 25 ~zl. 
The reaction product in the in vitro translation reaction was then resolved 
by SDS-PAGE. The [35S]methionine signal was quantified by means of a 
Fujix Bioimage Analyzer Bas 2000 System (Fuji Film Co.). 
Binding of Purified Recombinant ERM Proteins to the 
Insoluble Fraction of BHK Cell Lysate 
BHK cell  lysate  was prepared from a monolayer in a  10-cm dish  at 60- 
70%  confluence at 4°C. Cells were washed three times with PBS, scraped 
off using a rubber policeman in lysis buffer (0.06%  Nonidet P-40, 0.6% 
glycerol,  130 mM KC1, 20 mM NaCl,  1 mM sodium orthovanadate, 2 mM 
MgClz, 0.1  mM EGTA. 1 mM EDTA, 1 mM DTT, 10 mM Hepes, pH 
7.4,  l  mM PMSF,  and 10 ~g/ml leupeptin), and then disrupted by three 
strokes in a loose-fitting teflon glass homogenizer. The protein concentra- 
tion of each lysate  was adjusted to 12 mg/ml using the lysis buffer. The 
protein concentration was estimated from the absorbance at 280 nm using 
BSA as the standard, after 5 ILl of the cell lysate was completely solubi- 
lized by 95 p,I of 2 N NaOH. The BHK cell lysate (5 Ixl) was brought to 10 
p,l with 1/15 PBS (1 mM sodium phosphate solution, pH 7.5, and  l0 mM 
NaCl). To examine the effect  of GTP~,S, 2 p,l of 10 mM GTP~/S, pH 7.5, 
and 3 ~l of 1/15 PBS were added to the BHK cell lysate  (5 Ixl), and to ex- 
amine the effect  of C3, 2 ixl of l0 mM GTP~/S, pH 7.5, 2 ~l of 0.75 mg/ml 
of C3  toxin, and  1 Ixl of 10  mM NAD + were added  to the  cell  lysate. 
Thereafter, 5 ill of purified ezrin,  radixin,  or moesin (~0.16 mg/ml eluate 
from the monoQ column in ~50  mM KCI/10  mM Hepes, pH 7.5)  was 
added and incubated for 8 h at 4°C, followed by centrifugation at 300,000 g 
for 10 min in a 7  ×  20 rnm tube (Optima TL Ultracentrifuge; Beckman 
Instrs., Fullerton, CA). The insoluble fraction recovered as a pellet  was 
washed with the lysis buffer without Nonidet P-40/glycerol  and resolved 
by SDS-PAGE. The amount of ERM proteins in the insoluble fraction 
was estimated by comparing the staining intensity of each band in immu- 
noblotting with that of the various amounts of authentic ERM proteins re- 
solved by electrophoresis and immunoblotted on the same nitrocellulose 
sheet. 
Exposing Living BHK Cells with C3 Toxin 
BHK cells cultured to 80-90% confluence were incubated with 100 p,g/ml 
C3 toxin in 1 ml of Opti-MEM medium (GIBCO BRL) in the presence of 
10 ~1 of lipofectamin (GIBCO BRL) for 4 h. Control cells were incubated 
with the same culture medium without C3 toxin for 6 h. To compare the 
amount of soluble and insoluble ERM proteins, cells exposed or not to C3 
toxin were homogenized in a physiological  solution consisting of 130 mM 
KC1, 20 mM NaC1. 1 mM MgCl2, 10 mM Hepes, pH 7.5, 1 mM p-amidi- 
noPMSF, and 0.01 mg/ml of leupeptin. After centrifugation at 300,000 g 
for 20 min, the amount of ERM proteins in the pellet and supernatant was 
quantified by immunoblotting using anti-ERM pAb 11. The cells exposed 
or not to C3 toxin in 60-mm dishes were immunoprecipitated with anti- 
CD44 mAb (mAb30189) as described above, and the immunoprecipitates 
were separated by  SDS-PAGE followed by immunoblotting with  anti- 
ERM pAb I1. 
SDS-PA  GE and Immunoblotting 
One-dimensional SDS-PAGE (7.5-18%) proceeded essentially  according 
to Laemmli  (1970),  and  the gels were stained with Coomassie brilliant 
blue R-250. For immunoblotting, proteins were electrophoretically trans- 
ferred from gels to nitrocellulose membranes, which were incubated with 
the first antibody. Bound antibodies were visualized  with alkaline  phos- 
phatase-conjugated goat anti-rabbit IgG and the appropriate substrates 
as described by the manufacturer (Amersham International). 
One-dimensional  Peptide Mapping 
Protein bands were excised from the SDS-polyacrylamide gels, immersed 
in the sample buffer, and then subjected to limited  proteolysis with Sta- 
phylococcus  aureus V8 protease in  18%  SDS-polyacrylamide gels as de- 
scribed by Cleveland  et al. (1977). The [35S]methionine signal was quantified 
by means of a Fujix Bioimage Analyzer Bas 2000 System (Fuji Film Co.). 
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teins  used  in  the  in  vitro 
binding  assay. Fusion  pro- 
teins  between  GST  and  the 
cytoplasmic domain of mouse 
CD44 (GST-CD44cyt), mouse 
ezrin,  radixin, and  moesin 
produced  by  means  of  re- 
combinant baculovirus infec- 
tion were purified  to homo- 
geneity.  GST  was  produced 
in E. coli. The mobility of the 
molecular markers  is  shown 
on the  left  (110, 88,  48,  33, 
and  29-kD, from  the  top), 
and  each  band  was  stained 
with Coomassie brilliant blue. 
Results 
In Vitro Binding Assay between GST-CD44cyt and 
ERM Proteins 
To obtain a large amount of purified native ERM proteins 
for the  in  vitro  binding  assay,  we  overexpressed  mouse 
ezrin, radixin, or moesin in insect Sf9 cells by means of re- 
combinant baculovirus infection. The overexpressed ERM 
proteins were then purified to homogeneity through two 
chromatographic steps and used for the in vitro binding as- 
say (Fig. 1). A  fusion protein between GST and the cyto- 
plasmic domain of mouse CD44 (GST-CD44cyt) was first 
expressed in E. coli and purified. However, this fusion pro- 
tein was degraded into smaller fragments very rapidly in 
E.  coli,  making it  very difficult  to  purify the  full-length 
GST-CD44cyt required for the in vitro binding assay. We 
thus overexpressed GST-CD44cyt in Sf9 cells by recombi- 
nant baculovirus infection and found that it was stable in 
Sf9 cells. This product was used for the in vitro binding as- 
say (Fig. 1). 
GST-CD44cyt produced  in  the  Sf9  system  was  incu- 
bated  with  glutathione-Sepharose  beads.  After washing, 
purified recombinant ezrin, radixin, or moesin was added 
to the beads.  After incubation and washing, the proteins 
associated with  GST-CD44cyt were  eluted with  a  buffer 
containing glutathione, resolved by SDS-PAGE, and then 
immunoblotted with anti-ezrin, -radixin, or -moesin mAb. 
The control was GST produced in E. coli instead of GST- 
CD44cyt. All binding assays were performed at low and at 
physiological ionic strength (40 and 150 mM KC1, respec- 
tively). In some experiments, we used GST fusion proteins 
with the cytoplasmic domain of mouse E-cadherin as addi- 
tional controls. 
As shown in Fig. 2, at low ionic strength, ezrin, radixin, 
and moesin bound to the cytoplasmic domain of CD44. By 
contrast, at physiological ionic strength, they bound very 
weakly to GST-CD44cyt. Control experiments with GST 
as well as with GST/cadherin showed that the nonspecific 
background binding was negligible. 
Using this assay, the interaction of moesin with CD44cyt 
was  quantified  by determining  the  relationship  between 
the  amount  of  "bound"  moesin  on  beads  and  that  of 
moesin in the incubation solution. The ratio of bound to 
total moesin over a range of 0-100 pmol was estimated by 
Figure 2.  Association  of ezrin, radixin, and  moesin with GST- 
CD44cyt-bound  beads. GST-CD44cyt or GST bound  to gluta- 
thione-Sepharose beads was incubated with purified recombinant 
ezrin, radixin, or moesin at low (40 mM KCI) or physiological 
ionic strength (150 mM KCI). After washing, the protein associ- 
ated  with GST-CD44cyt (F) or GST  (G)  was eluted  from  the 
beads with a buffer containing glutathione. Proteins  in the glu- 
tathione  eluate were separated  by SDS-PAGE followed by im- 
munoblotting with anti-ezrin, anti-radixin, or anti-moesin mAbs. 
The bands of ezrin, radixin, and moesin are indicated by E, R, 
and M on the left. 
subtracting the  amount on control GST beads from that 
on GST-CD44cyt beads. As shown in Fig. 3, at low ionic 
strength, moesin binding to CD44cyt was saturable.  Scat- 
chard analysis determined the dissociation constant to be 
9.3  -+ 1.6 nM (Fig.  3 b, Inset).  The CD44cyt/moesin inter- 
action  at  physiological ionic  strength  was  too  weak  for 
quantitation. 
Effects of Phospholipicls on the CD44cytlERM Binding 
We investigated the regulation mechanism for the CD44/ 
ERM interaction by means of this binding assay. Consid- 
ering that many of the cellular events occurring just  be- 
neath the plasma membranes are regulated by phospholipids, 
we  studied  the  effects  of various  phospholipids  on  the 
CD44/ERM interaction in vitro. As shown in Fig. 4, neither 
PS nor PC affected CD44/radixin or CD44/moesin interac- 
tion, whereas phosphoinositides significantly enhanced it 
at physiological ionic strength. PI, 4-PIP, and 4,5-PIP2  ap- 
parently  enhanced  the  binding  of radixin  or  moesin  to 
GST-CD44cyt, although  there  was  a  slight  background 
binding to control GST. The effect of this enhancement 
of these  three  phosphoinositides  was  in  the  order  of 
PI<4-PIP<4,5-PIP2, as shown in Fig.  4. The dissociation 
constant  between  CD44cyt and  moesin  at  physiological 
ionic strength in the presence of 4,5-PIP2 was determined 
to be 9.3 _+ 4.8nM, according to the method described above. 
The  CD44/ezrin  interaction  also  appeared  to  be  en- 
hanced by phosphoinositides. However, for unknown rea- 
sons, ezrin showed a relatively high affinity for Sepharose 
beads in the presence of phosphoinositides, making it diffi- 
cult to conclusively evaluate the phosphoinositide depen- 
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Figure 3.  Quantitative analy- 
sis  of  the  binding  between 
moesin and GST-CD44cyt at 
40 mM KC1. (a)  Estimation 
of  the  amount  of  "bound" 
moesin. Recombinant moesin 
(0.75-96 pmol) was added to 
the  GST-CD44cyt  or  GST 
beads, and 15% of each glu- 
tathione  eluate  was  applied 
to each lane of SDS-PAGE. 
The  silver staining intensity 
of  moesin  band  in  glu- 
tathione  eluates  (/eft) was 
compared  with that  of  the 
various  amounts  of authen- 
tic purified  moesin  resolved 
and silver stained in the same 
gel (right). (b) Binding mode 
of moesin  to  GST-CD44cyt 
beads.  After  subtraction  of 
the  GST-dependent  back- 
ground  binding, the  amount 
of bound versus added moesin 
(0-100  pmol)  was  plotted. 
Scatchard analysis (Inset) de- 
termined that the K d  was 9.3 
_+ 1.6 nM. 
dence  of the  CD44/ezrin  interaction.  To  overcome this 
technical  difficulty,  we  directly  conjugated  recombinant 
ezrin (and also radixin as a control) with CNBr-activated 
Sepharose  beads  and  analyzed  the  interaction  between 
those and soluble  GST-CD44cyt in the  absence or pres- 
ence  of 4,5-PIP2  at physiological ionic strength.  Fig.  5 a 
shows that in the absence of 4,5-PIP2, only a small amount 
of GST-CD44cyt was specifically bound to the ezrin beads, 
whereas in the presence of 4,5-PIP2,  this binding was re- 
markedly enhanced, an effect that was also observed be- 
tween radixin beads and GST-CD44cyt. Using the ezrin- 
coupled Affigel beads, we  further confirmed the  similar 
phospholipid  dependence  of  CD44/ezrin  interaction  to 
that of CD44/radixin and CD44/moesin, which was shown 
using GST-CD44cyt beads (Fig. 5 b). Taken all together, 
we conclude that the  direct interaction of ezrin,  radixin, 
and moesin with the cytoplasmic domain of CD44 is re- 
markedly enhanced by phosphoinositides, especially 4,5-PIP2. 
Binding Affinity of  ERM Proteins for Phosphoinositides 
The enhancement of the CD44/ERM interaction by phos- 
phoinositides suggested that either ERM proteins or the 
cytoplasmic domain of CD44, or both, have binding affin- 
ity for phosphoinositides. We evaluated the binding affin- 
ity of ERM proteins and GST-CD44cyt for various phos- 
pholipids using gel filtration chromatography (Fig. 6). 
Phospholipids  were  eluted  in  the  void volume from a 
Superose  12R  10/30  column,  due  to  micelle  formation. 
ERM proteins were eluted at a position corresponding to 
an apparent molecular mass of ~60 kD. As shown in Fig. 6 a, 
purified recombinant moesin was incubated with various 
phospholipids and passed through the column. An incuba- 
tion  with  PS,  PC,  or  PI  did  not  affect  the  behavior  of 
moesin in the column. In sharp contrast, when moesin was 
incubated with 4-PIP or 4,5-PIP2, it coeluted with 4-PIP or 
4,5-PIP2 in  the  void volume. The  same  results  were  ob- 
tained  using  purified  recombinant  ezrin  and  radixin.  A 
similar binding assay by means of gel filtration was per- 
formed between various lipids and GST-CD44cyt. None of 
PS,  PC,  PI, 4-PIP, or  4,5-PIP2 affected  the  behavior  of 
GST-CD44cyt in the column (Fig. 6 b). 
Phosphoinositide-independent  Binding of 
the Amino-terminal Half of  Moesin to the 
Cytoplasmic Domain of CD44 
We  produced  amino-  and  carboxyl-terminal  halves  of 
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and moesin with the cytoplasmic domain of CD44. As described 
in Fig. 2, radixin or moesin was incubated with GST-CD44cyt or 
GST bound  to beads  at physiological ionic strength  in the  ab- 
sence (C) or presence of phosphatidylserine (PS), phosphatidyl- 
choline  (PC), phosphatidylinositol  (P/),  phosphatidylinositol 
4-phosphate  (PIP), or  phosphatidylinositol  4,5-bisphosphate 
(PIP2). After washing, the protein associated with GST-CD44cyt 
(F) or GST (G) was eluted from the beads with a buffer contain- 
ing glutathione. Proteins in the glutathione eluate were separated 
by SDS-PAGE and then immunoblotted with antiradixin or anti- 
moesin mAbs. 
mouse moesin by means of recombinant baculovirus infec- 
tion, purified them to homogeneity, then incubated them 
with the GST-CD44cyt beads at low or physiological ionic 
strength in the absence or presence of 4,5-PIP  2 (Fig. 7). In 
sharp  contrast to full-length moesin,  the  amino-terminal 
half bound to GST-CD44cyt not only at low, but also at 
physiological ionic strength in the absence of 4,5-PIP2,  in- 
dicating that the binding between GST-CD44cyt and the 
amino-terminal  half  of  moesin  at  physiological  ionic 
strength  did  not  require  4,5-PIP2.  The carboxyl-terminal 
half of moesin did not have any binding affinity for GST- 
CD44cyt under any of the conditions tested. 
Rho-GDI Coimmunoprecipitated with the CD441 
Moesin Complex 
The above in vitro findings suggest that the formation of 
CD44/ERM complex is dynamically regulated in vivo. As 
a first step to examine the in vivo regulation mechanism of 
Figure 5.  Association  of GST-CD44cyt with ezrin- or radixin- 
coupled  beads. (a)  Ezrin-  or radixin-coupled  Sepharose  beads 
(Ezrin or Radixin, respectively)  were  incubated  with purified 
GST-CD44cyt (F)  or GST  (G)  at  physiological ionic strength 
(150 mM KC1) in the absence (-PIP2) or presence (+PIP2) of 
phosphatidylinositol 4,5-bisphosphate, and bound proteins were 
eluted  with SDS-PAGE sample buffer. The eluates were sepa- 
rated  by SDS-PAGE and  then  immunoblotted  with anti-GST 
pAb. (b) Ezrin-coupled Affigel beads were incubated with puri- 
fied GST-CD44cyt at physiological ionic strength (150 mM KCI) 
in the presence of phosphatidylserine (PS), phosphatidylchorine 
(PC),  phosphatidylinositol  (P1), phosphatidylinositol  4-phos- 
phate (PIP), or phosphtidylinositol 4,5-bisphosphate (PIP2), and 
bound proteins were eluted with SDS-PAGE sample buffer. The 
eluates were resolved by electrophoresis and stained with Coo- 
massie brilliant blue. 
this complex formation, we immunoprecipitated the CD44/ 
moesin complex from cultured BHK cells  (Tsukita et al., 
1994)  and reexamined its constituents, focusing upon the 
small  molecular  mass  range.  Cultured  BHK  ceils  were 
metabolically  labeled  with  [35S]methionine,  solubilized 
with RIPA buffer, and then immunoprecipitated with anti- 
moesin  mAb,  CR-22.  The  immunoprecipitate  was  re- 
solved in 12.5%  SDS-polyacrylamide gels in the absence 
of mercaptoethanol to bring the IgG in the sample into the 
high  molecular  mass  region.  These  conditions  allowed 
small molecular mass constituents of the immunoprecipi- 
tates to be analyzed by autoradiography (Fig. 8 a). 
As compared with the control immunoprecipitate, that 
of moesin reproducibly contained at least three low molec- 
ular mass polypeptides (55, 30, and 25 kD) in addition to 
moesin and  CD44 (Tsukita  et  al.,  1994).  To exclude the 
possibility of nonspecific binding of these polypeptides to 
the  immunoprecipitate,  we  added  the  excess  amount  of 
purified  unlabeled  recombinant  moesin  into  the  lysate 
from [35S]methionine-labeled BHK cells  before immuno- 
precipitation (Fig.  8 b).  As a  result of competition, most 
[35S]methionine-labeled bands (three low molecular mass 
polypeptides [55, 30, and 25 kD], moesin, and CD44) were 
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Figure 6.  Binding affinity of ERM proteins and the cytoplasmic 
domain of CD44 with phospholipids. (a) Interaction of moesin 
with phospholipids. Purified recombinant moesin was incubated 
without (Moesin) or with phosphatidylserine (PS), phosphatidyl- 
choline  (PC), phosphatidylinositol (P/),  phosphatidyl-inositol 
4-phosphate (PIP),  or phosphatidylinositol  4,5-bisphosphate (PIP2) 
and passed through a column containing Superose 12R gel. Elu- 
tion profiles of moesin were obtained by ELISA with anti-moesin 
mAb. An incubation of moesin with PS, PC, or PI did not affect 
its behavior in the column. By contrast, when moesin was incu- 
bated with 4-PIP or 4,5-PIP2, it coeluted with 4-PIP or 4,5-PIP2 in 
the void volume. 4-PIP and 4, 5-PIP2 had the same effect upon 
ezrin and radixin (data not shown). (b) Binding affinity of GST- 
CD44cyt with 4,5-PIP2.  Incubating GST-CD44cyt with 4,5-PIP  2 
did not affect its binding behavior. 
Figure 7.  Interaction of amino- and carboxyl-terminal halves of 
moesin with GST-CD44cyt beads. As described in the legend to 
Fig. 2, the amino- or carboxyl-terminal half of moesin (N-Moesin 
and C-Moesin, respectively) was incubated with GST-CD44cyt- 
or GST-bound beads at low (40 raM) or at physiological ionic 
strength (150 raM) in the  absence or presence (+PIP2) of 4,5- 
PIP  2. After washing, the protein associated with GST-CD44cyt 
(F) or GST (G) was eluted from the beads with a buffer contain- 
ing glutathione, Proteins in the glutathione eluate were separated 
by SDS-PAGE and then immunoblotted with anti-ERM pAbs 
(p-800 and I1) for the amino- and carboxyl-terminal halves, re- 
spectively. The bands of C- and N-moesin are indicated by C and 
N on the left. 
removed  from  the  immunoprecipitate,  indicating  that 
these  low  molecular  mass  polypeptides and  CD44  were 
specifically precipitated  with  anti-moesin  mAb  through 
their association with moesin. 
To  identify these  low molecular mass components, we 
analyzed the cross-reactivity of various antibodies specific 
to known cytoplasmic proteins. Considering that the Rho- 
signaling pathway plays a key role in the regulation of actin 
filament/plasma  membrane  association,  we  investigated 
whether or not there were Rho and/or Rho regulators in 
the above moesin immunoprecipitate. The molecular mass 
of Rho is around 21  kD, so we concluded that Rho itself 
was not included in the immunoprecipitate.  Among Rho 
regulators, the molecular mass of Rho-GDI is reportedly 
~30 kD (Fukumoto et al., 1990). Then we checked whether 
or not the 30-kD band in the moesin immunoprecipitate is 
identical to Rho-GDI. 
The  moesin  immunoprecipitate  was  resolubilized  and 
reimmunoprecipitated  with  anti-mouse  Rho-GDI  mAb. 
As shown in Fig. 9 a, most of the 30-kD band was specifi- 
cally reimmunoprecipitated by this mAb, leaving the other 
bands  in  the  supernatant.  Since  this  mAb  was  raised 
against mouse Rho-GDI, we examined its specificity using 
hamster Rho-GDI. When BHK cells were immunoprecipi- 
tated  with  the  anti-mouse  Rho-GDI  mAb,  a  30-kD 
polypeptide was specifically recognized (Fig. 9 a). Further- 
more, we compared the 30-kD band in the moesin immu- 
noprecipitates  with  the  in  vitro  translated  mouse  Rho- 
GDI by one-dimensional peptide mapping.  As shown  in 
Fig. 9 b, the peptide map of the 30-kD band was very simi- 
lar to that of in vitro translated mouse Rho-GDI. We thus 
concluded  that  Rho-GDI  is  tightly  associated  with  the 
CD44/moesin complex in vivo. 
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teins with the CD44/ERM complex. (a) Cultured BHK cells were 
metabolically  labeled  with  [35S]methionine,  solubilized  with 
RIPA  buffer,  and  then  immunoprecipitated with  anti-moesin 
mAb CR-22 or nonimmune mouse IgG. The immunoprecipitate 
(anti-moesin mAb or IgG, respectively) was separated in a  15% 
SDS-polyacrylamide gel in the  absence of mercaptoethanol to 
bring the IgG band to the high molecular mass regions and quan- 
tified by image analysis. In addition to CD44 (see Tsukita et al., 
1994),  three bands around 55, 30, and 25-kD coimmunoprecipi- 
tated with moesin (M). (b) Purified, unlabeled moesin was added 
to the RIPA lysate of [3SS]methionine-labeled BHK cells and im- 
munoprecipitated with anti-moesin mAb CR-22 or nonimmune 
mouse IgG (anti-moesin mAb or IgGo respectively). [35S]methio- 
nine-labeled bands of 55, 30, and 25-kD as well as CD44 were un- 
detectable, although a weakly labeled moesin band was evident. 
Figure 9.  Identification of the 30-kD polypeptide in the moesin 
immunoprecipitate as a hamster Rho-GDI. (a) Specific recogni- 
tion of the 30-kD peptide by anti-mouse Rho-GDI mAb. The 
moesin immunoprecipitate (see Fig. 8) was solubilized from the 
beads with high salt, and then  the eluate (high salt eluate) was 
again immunoprecipitated with anti-mouse Rho-GDI mAb (anti- 
rhoGD1) or non-immune mouse IgG. The 30-kD band (arrow) 
was  specifically immunoprecipitated,  leaving  the  supernatant 
lacking the 30-kD band (supernatant). This anti-mouse Rho-GDI 
mAb specifically immunoprecipitated a  polypeptide with a  mo- 
lecular mass of 30-kD from the BHK cells metabolically labeled 
with  [35S]methionine  (anti-rhoGDl from  BHK cells). (b)  One- 
dimensional  peptide  mapping.  Mouse  Rho-GDI,  which  was 
translated in a cell-free system then labeled with [35S]methionine 
using  a  rabbit  reticulocyte lysate, and  the  30-kD  band  in  the 
moesin immunoprecipitate from BHK cells (see Fig. 8) were ana- 
lyzed by one-dimensional peptide mapping using Staphylococcus 
aureus V8 protease. The map of mouse Rho-GDI was very simi- 
lar to that of the hamster 30-kD band. 
Binding of Recombinant ERM Proteins 
to the Insoluble Fraction of Crude Cell Homogenate Is 
Suppressed by C3 Toxin 
To  initially  evaluate  the  notion  that  the  formation  of 
CD44/ERM  complex  is  regulated  by  the  Rho-signaling 
pathway, we examined whether or not a GTP-binding pro- 
tein is involved in regulating the binding of ERM proteins 
to  the  insoluble  components  of  cells  including  plasma 
membranes.  For this  purpose,  we  established a  cell-free 
system that allowed the estimation of ERM binding affin- 
ity to  the  insoluble components.  Since  we  identified the 
CD44/ERM  complex in  BHK  cells by immunoprecipita- 
tion, we used the same cells in this experiment. 
BHK  cells  were  lysed  in  lysis  buffer  at  physiological 
ionic  strength  containing  0.06%  Nonidet  P-40,  and  the 
protein  concentration  in  the  lysate was  adjusted  to  ,-,d2 
mg/ml. To estimate the  binding affinity of ERM  proteins 
to  the  insoluble fraction,  recombinant  ezrin,  radixin,  or 
moesin  was  added  and  incubated  with  the  lysate.  When 
~0.8  ~g of ezrin, radixin, or moesin was added to the ly- 
sate to a  final volume of 15  p~l, ~0.05  ~g of each protein 
was recovered in the insoluble fraction after centrifugation 
(Fig, 10 a). The amount of endogenous ERM proteins re- 
covered in the  insoluble fraction was too small to be de- 
tected under our experimental conditions. The amount of 
recovered protein was estimated by comparing the stain- 
ing intensity of each band in immunoblotting with that of 
the various amounts of authentic ERM  proteins resolved 
by electrophoresis and immunoblotted on the same nitro- 
cellulose sheet (Fig. 10 b). When the amount of ERM pro- 
teins added was increased, their binding to  the  insoluble 
fraction was saturable; at the level of ~0.8 ~g added ERM 
proteins, binding was saturated sufficiently. Upon adding 
GTP',/S to the incubation system, the amount of recovered 
ezrin, radixin, and moesin  was increased  1.9  +  0.5-fold, 
2.l  +-  0.3-fold, and 3.1  +-  1.3-fold, respectively, averaged 
from four experiments. This suggested that the GTP~/S ac- 
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proteins with the insoluble fraction of BHK cell lysate. (a) Immu- 
noblot  analyses.  After ~0.8  ~g recombinant  ezrin,  radixin,  or 
moesin was incubated with the BHK cell  homogenate followed 
by  centrifugation,  the  pellet  was  analyzed by  immunoblotting 
with anti-ERM pAb I1. Under these conditions, the amount of 
endogenous ERM proteins was too small to be detected as com- 
pared  to that  of added  ERM  proteins,  and  ~0.05  ~g of each 
ERM protein was recovered in the insoluble  fraction (Control). 
When GTP~/S was added to the incubation mixture, the amount 
of recovered ERM proteins in the insoluble fraction was signifi- 
cantly increased  (GTPyS). C3  toxin  markedly suppressed  the 
binding of each ERM  protein  to the  insoluble  fraction in the 
presence (GTPyS+C3) as well as in the absence (C3) of GTP',/S. 
The bands of ezrin, radixin,  and moesin are indicated by E, R, 
and M, respectively, on the left.  (b) Relative binding ability  of 
ERM proteins to the insoluble fraction. The amount of recovered 
protein was estimated by comparing the staining intensity of each 
band in immunoblotting with that of the various amounts of au- 
thentic ERM proteins resolved by electrophoresis and immuno- 
blotted on the same nitrocellulose sheet. A relative binding abil- 
ity of 1 was equivalent to the amount of recovered ezrin, radixin, 
or moesin in the insoluble fraction for each experiment. Values 
represent relative  binding abilities averaged from four experiments 
-2_ SEMs. 
tivation  of some  GTP-binding  protein  in  cell  lysates  in- 
creases the ERM binding ability to the insoluble fraction. 
C3 toxin, a specific Rho inactivator, was added to the in- 
cubation mixture with NAD +. As shown in Fig.  10 a, the 
binding ability of ERM proteins  to the insoluble fraction 
of the lysate was remarkedly suppressed  by C3 toxin at a 
concentration of 0.l mg/ml, In the presence of GTP~/S, C3 
toxin  reduced  the  binding  affinity  of ezrin,  radixin,  and 
moesin  to 21  +_  10%,  29  +_  5%,  and  50  _  35%,  respec- 
tively, of the value in the absence of C3 toxin and GTPyS 
(control value). Also in the absence of GTP',/S, the respec- 
tive binding affinities  were  reduced  by C3 toxin  to 23  _+ 
11%, 25  +- 12%, and 32  +_ 30%  of the control value, sug- 
gesting that there was some stimulation by endogenous ac- 
tive  Rho in the  lysate.  As a  control, we  added  the  same 
amount of BSA or IgG to the BHK cell lysate instead  of 
ERM  proteins,  and  no  Rho-dependent  binding  of these 
proteins was identified.  As another control, we added the 
recombinant ERM proteins to the same amount of buffer 
instead  of the BHK cell lysate,  and no GTP~/S/C3  toxin- 
dependent  precipitation  of ERM  proteins  was  observed, 
These results indicated that activated Rho is required  for 
the interaction between the insoluble fraction and recom- 
binant ERM proteins. 
Binding of Recombinant ERM Proteins to the 
Insoluble Fraction of BHK Cell Lysate Is Suppressed 
by an Anti-CD44 Cytoplasmic Domain mAb 
We studied whether the Rho-dependent association of ex- 
ogenous ERM proteins with the insoluble fraction can be 
attributed  to the  CD44/ERM  or other unknown  interac- 
tions. We raised mAbs using the GST fusion protein with 
the cytoplasmic domain of mouse CD44 as the antigen in 
rats  and then  studied  whether  or not they interfere  with 
the  Rho-dependent  association  of ERM  proteins  in  the 
presence  of GTP~/S.  We  obtained  one  mAb  (45-4),  that 
recognized  the  cytoplasmic domain  of hamster  CD44  as 
well as mouse CD44 on immunoblots  (Fig.  11 a).  When 
0.5 txg of purified mAb 45-4 was added to 15 ~l of the in- 
cubation solution, the binding affinity of ERM proteins to 
the insoluble fraction was suppressed (Fig. 11 b) to a level 
that was almost equivalent to that of C3 toxin. In contrast, 
nonimmune  rat  IgG  did  not  affect  the  association.  Fur- 
thermore, this mAb effectively interfered with the in vitro 
binding  of  recombinant  moesin  with  GST-CD44cyt  at 
physiological  ionic  strength  in  the  presence  of 4,5-PIP2, 
while control nonimmune IgG did not affect this interac- 
tion (Fig. 11 c). 
C3 Toxin Interferes with ERM-Plasma Membrane 
Interaction in Living Cells 
We examined the effect of C3 toxin on the ERM-plasma 
membrane interaction in living BHK cells. This strategy is 
however, technically  difficult.  C3 toxin-induced  morpho- 
logical changes (rounding up of cells) are undetectable for 
12 h  in living BHK cells, and the effect is not particularly 
synchronized among treated cells. To circumvent this diffi- 
culty,  we  introduced  C3  toxin  into  cells  using  the  lipo- 
fectamin, which rather clarified its effect. 
After a 6-h incubation with the lipofeetamin-conjugated 
C3 toxin, BHK cells were homogenized in PBS  and then 
divided into soluble and insoluble fractions by centrifuga- 
tion. From the untreated BHK cells, ~30% of the endoge- 
nous ERM proteins were recovered in the insoluble frac- 
tion,  whereas  only  a  trace  amount was  recovered  in  the 
insoluble  fraction  obtained  from  C3  toxin-treated  cells 
(Fig. 12 a). The untreated and C3 toxin-treated BHK cells 
were  lysed  with  RIPA  buffer  and  immunoprecipitated 
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domain of CD44 as a binding 
partner in the insoluble frac- 
tion  of BHK  cell  lysate  for 
recombinant  ERM  proteins. 
(a)  Specificity  of mAb 45-4 
for  the  cytoplasmic  domain 
of  mouse  CD44.  Immuno- 
blotting  of the  lysate  of Sf9 
cells  expressing the GST fu- 
sion  protein  with  the  cyto- 
plasmic  domain  of  mouse 
CD44  (GST-CD44cyt)  or 
the lysate of E. coli express- 
ing  the  GST  protein  with 
anti-GST pAb or mAb 45-4. 
Anti-GST  pAb  recognized 
both  GST-CD44cyt  (arrow) 
and  GST  (arrowhead), 
whereas  mAb  45-4  recog- 
nized only GST-CD44cyt. (b) 
The  same  binding  experi- 
ments  were  performed  as 
those  shown  in  Fig.  10,  ex- 
cept  that  C3  toxin  was  re- 
placed with the purified mAb 
45-4.  As  controls,  non- 
immune  rat  IgG was  added 
instead  of mAbs (IgG). The 
mAb  45-4  markedly  sup- 
pressed the binding of recom- 
binant  ERM  proteins.  The 
bands  of ezrin,  radixin,  and 
moesin are indicated by E, R, 
and  M  respectively,  on  the 
left.  (c)  Effects of the  mAb 
45-4 on the association  of re- 
combinant  moesin  with  the 
GST-CD44cyt beads at phys- 
iological  ionic strength in the 
presence  of 4,  5-PIP  2.  Puri- 
fied mAb 45-4  (+mAb45-4) 
or control nonimmune IgG (+IgG) was added to the incubation mixture at a final concentration of 30 ixg/ml. Moesin bound to GST- 
CD44cyt (F) or GST (G) was eluted and detected by immunoblotting with anti-moesin mAb. 
with anti-CD44 antibody (Fig. 12 b). From untreated BHK 
cells, some ERM proteins were recovered and detected by 
immunoblotting in the CD44 immunoprecipitate,  whereas 
ERM  proteins  were  virtually  undetectable  in  the  CD44 
immunoprecipitate from the C3 toxin-treated cells. 
Discussion 
ERM Proteins Directly Bind to the 
Cytoplasmic Domain of CD44 as a 4,5-PIP2-dependent 
Manner In Vitro 
We  found that  ERM proteins  coimmunoprecipitate  with 
CD44 (Tsukita  et al.,  1994).  However, so far in vitro evi- 
dence for a direct association between the cytoplasmic do- 
main of CD44 and ERM proteins has not been obtained. 
Here, using an in vitro binding assay, we revealed that at 
low ionic strength  (40  mM  KC1),  ERM  proteins  directly 
bind to the cytoplasmic domain of CD44 at relatively high 
affinity (Kd of moesin is 9.3  _+  1.6 nM).  Although this di- 
rect  binding  became  undetectable  at  physiological  ionic 
strength  (150  mM  KC1),  4,5-PIP2  facilitated  the  CD44 
binding of ERM proteins (Ka of moesin is 9.3  _+ 4.8 nM). 
Thus,  we  concluded  that  ERM  proteins  directly  bind  to 
the  cytoplasmic domain  of CD44  in  a  regulated  manner 
and that ezrin, radixin, and moesin are essentially indistin- 
guishable  with  respect  to their  binding capacity with  the 
cytoplasmic domain of CD44. 
Many actin-modulating proteins,  such  as gelsolin  (Jan- 
mey and Stossel,  1987), gCap39 (Yu et al.,  1990), profilin 
(Lassing  and  Lindberg,  1985),  cofilin  (Yonezawa  et  al., 
1991), and a-actinin (Fukami et al.,  1992) reportedly bind 
to 4,5-PIP2. 4,5-PIP2 induces  the  dissociation  of profilin- 
actin and gelsolin-actin complexes, and the interaction of 
cofilin with G- and F-actin is  also inhibited  by PI, 4-PIP, 
and 4,5-PIP2. Through these mechanisms, the structural in- 
tegrity of actin-based cytoskeletons is thought to be regu- 
lated depending on the level of phosphoinositides in vivo. 
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ing BHK cells. (a) BHK cells incubated in the presence (C3) or 
absence (-) of C3 toxin were homogenized in physiological solu- 
tion (see Materials  and Methods)  and then divided into soluble 
supernatant (S) and insoluble  pellet (P) fractions  by centrifuga- 
tion. Each fraction  was resolved by SDS-PAGE, and ERM pro- 
teins were detected by immunoblotting with anti-ERM pAb I1. 
In the insoluble  fraction of untreated BHK cells (-), ~30% of 
the  total  ERM  proteins  was  recovered, whereas  only  a  trace 
amount  was  recovered  in  the  insoluble  fraction  of C3  toxin- 
treated cells (C3). (b) The RIPA lysates of C3 toxin-treated (C3) 
or untreated (-) BHK cells were immunoprecipitated by mAb 
30189, which is specific for the extracellular  domain of hamster 
CD44,  and  each  immunoprecipitate  was  immunoblotted  with 
anti-ERM pAb I1. ERM proteins were reproducibly  detected in 
the CD44 immunoprecipitate in the absence  of C3 toxin  as de- 
scribed  (Tsukita  et al., 1994), whereas  they were hardly detect- 
able in the immunoprecipitate in the presence of C3 toxin. 
The interaction of ERM proteins with the cytoplasmic do- 
main  of  CD44  is  enhanced  by  4,5-PIP2,  increasing  the 
number of actin filament-association sites on the cytoplas- 
mic surface of plasma membranes. This may also markedly 
affect the structural integrity of actin-based cytoskeletons. 
ERM  proteins  localize  and  function  just  beneath  the 
plasma membrane, so compared with other actin-modulat- 
ing proteins, they have many topological opportunities to 
interact with phosphoinositides, which are components of 
plasma membranes. 
The Mechanism by Which 4,5-PIP  2 Enhances the 
Association between the Cytoplasmic Domain of CD44 
and ERM Proteins 
This study revealed that  ERM  proteins bind to 4,5-PIP2 
with  high  affinity.  Considering  that  the  cytoplasmic do- 
main of CD44 does not have any affinity for 4,5-PIP2, the 
facilitation  of the  CD44/ERM  interaction  by 4,5-PIP2 is 
derived  not  from  artifactual  cross-linking  of  CD44  and 
ERM by 4,5-PIP2 micelles, but from the 4,5-PIP2-induced 
conformational  change  of  ERM  proteins.  During  the 
course of this study, Niggli et al. (1995) independently re- 
ported,  using  different  techniques,  that  4,5-PIP2  binds 
ezrin with high affinity and that its binding domain of ezrin 
has been narrowed down to the amino-terminal half. 
Several  studies  have  indicated  that  the  carboxyl- and 
amino-terminal  halves  of  ERM  proteins  have  distinct 
functions.  The  respective  halves bind  to  actin-based  cy- 
toskeletons and plasma membranes (Algrain et al.,  1993). 
Some in vitro and in vivo data suggested that the amino- 
terminal half of native ERM proteins interferes with the 
interaction of their carboxyl-terminal half with actin fila- 
ments (Turunen et al., 1994; Martin et al., 1995).  Actually, 
the amino-terminal half of ezrin binds to its carboxyl-ter- 
minal half directly (Gary and Bretscher, 1995). 
In this study, at physiological ionic strength in  the  ab- 
sence of phosphoinositides, full-length moesin very weakly 
bound  the  cytoplasmic  domain  of  CD44,  whereas  the 
amino-terminal half of moesin bound  with  high  affinity. 
This  indicated  not  only  that  the  amino-terminal  half  of 
moesin is responsible for its association with plasma mem- 
branes  (CD44)  but  also  that  in  native  moesin,  the  car- 
boxyl-terminal half suppresses the direct interaction of the 
amino-terminal half with the cytoplasmic domain of CD44. 
These findings indicate that the amino- and carboxyl-ter- 
minal halves of ERM  proteins suppress the  functions  of 
their carboxyl- and amino-terminal halves; that is, binding 
to actin-based cytoskeletons and plasma membranes, re- 
spectively. This mutual suppression mechanism would be 
very important for ERM proteins to function as molecular 
cross-linkers  between  actin  filaments  and  plasma  mem- 
branes. This study showed that 4,5-PIP2 can function as a 
key modulator to release this mutual suppression immedi- 
ately below the plasma membrane. 
Rho-GDI Is Associated with the CD44/Moesin 
Complex In Vivo 
To  examine  the  in  vivo  regulation  mechanism  of  the 
CD44/ERM  complex formation, we  reexamined  the  im- 
munoprecipitated CD44/moesin complex from BHK cells. 
Immunoprecipitation and peptide mapping revealed that 
this  immunoprecipitate  contained  not  only  moesin  and 
CD44  but  also  three  smaller  molecular  mass  proteins 
around 55,  30,  and 25 kD, and  that the 30-kD protein is 
identical  to  hamster Rho-GDI. So  far,  the  physiological 
function of Rho-GDI is not clear. Rho-GDI was originally 
thought  to form a  tight complex with  the  GDP-form of 
Rho to form a cytoplasmic pool (Araki et al., 1990).  How- 
ever, it may recruit cytoplasmic Rho to the plasma mem- 
brane to be activated there  as it is in  Rab-GDI (Novick 
and Garret, 1994; Horiuchi et al., 1995; Takai et al., 1995). 
The Rab molecule undergoes a cycle of localization cou- 
pled  with  that  of  nucleotide  exchange  and  hydrolysis 
(Novick and Garrett, 1994);  Rab remains soluble until the 
Rab/Rab-GDI complex interacts with the appropriate do- 
nor  membrane,  promoting  dissociation  from  Rab-GDI, 
membrane attachment and the exchange of GDP for GTP 
(Soldati  et  al.,  1994;  Ullrich  et  al.,  1994;  Horiuchi et  al., 
1995).  If this recycling pathway of Rab is also true of Rho, 
the occurrence of Rho-GDI in the CD44/moesin complex 
would indicate that this complex is a site where active Rho 
regulates the plasma membrane/actin filament interaction. 
The  immunoprecipitation results  agree with the  findings 
that  in  MDCK  cells  expressing  myc-tagged RhoA,  acti- 
vated Rho is reportedly translocated from the  cytoplasm 
to ERM-concentrated regions of plasma membranes (Ta- 
kaishi et at., 1995). 
In  our  immunoprecipitates,  probably because  of  the 
severe solubilizing conditions, Rho itself was not detected, 
leaving Rho-GDI bound to the complex. As far as we ex- 
amined, none of the available antibodies specific for Rho- 
related proteins such as Rho-GDS and Rbo-GAP recog- 
nized the other 55- and 25-kD bands in the immunoprecip- 
itate. The identification of these proteins will lead to a better 
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ERM complex. However, the small amount of these pro- 
teins recovered as immunoprecipitates makes this identifi- 
cation technically challenging. 
The CD44/ERM Complex Formation Is Regulated by 
Rho In Vivo 
To evaluate the  involvement of Rho in the  CD44/ERM 
complex formation, we developed a cell-free system with 
which to examine the binding affinity of exogenous ERM 
proteins to the insoluble fraction of the BHK cell lysate. 
Using  this  system, we found that  GTP~/S  facilitated the 
binding and that C3 toxin remarkedly suppressed it in the 
presence as well as in the absence of GTP~/S.  This indi- 
cated that the GTP form of Rho included in the cell lysate 
is required for this binding.  Furthermore, we found that 
one of the anti-CD44 cytoplasmic domain mAbs also ef- 
fectively suppressed  the  ERM  binding  to  the  insoluble 
fraction and that this mAb interfered with the association 
between ERM proteins and CD44 in vitro. We then con- 
cluded that most of the membrane binding partners in this 
BHK cell-free system are CD44 molecules and that the as- 
sociation between ERM proteins and the cytoplasmic do- 
main of CD44 is regulated by Rho. As described in the In- 
troduction,  there  are  other  potential  ERM  membrane 
binding partners.  It  remains  elusive whether or not  the 
binding of these possible partners  to ERM  proteins are 
also Rho dependent. 
Recently, ezrin was reported to be oligomerized possi- 
bly through phosphorylation (Berryman et al., 1995; Gary 
and  Bretscher,  1995).  This  nature  of ezrin  is  probably 
shared by radixin and moesin (Andreoli et al., 1994). The 
effective suppression  of ERM  binding  to  the  insoluble 
fraction by an anti-CD44 cytoplasmic domain mAb, how- 
ever, indicates  that our cell-free system detected CD44/ 
ERM interaction rather than ERM oligomerization. 
The results  obtained from the  incubating  living BHK 
cells with C3 toxin also favored the notion that the forma- 
tion of CD44/ERM complex is dependent on active Rho. 
C3 toxin in living cells recruited most insoluble ERM pro- 
teins to the soluble pool, leaving CD44 free from ERM 
proteins. Considering that the effect of C3 toxin in living 
cells is not sharp in terms of its time course and synchroni- 
zation, the effect observed in living cells is highly compati- 
ble to that observed in our cell-free system. 
Ridley and  Hall (1992)  and  Ridley et al.  (1992)  have 
found using serum-starved Swiss 3T3 cells that Rho plays a 
central role in the coordinated assembly of focal adhesions 
and stress fibers induced by growth factors, and that Rac 
stimulates actin filament accumulation at the plasma mem- 
brane, forming membrane ruffles. Furthermore, Cdc42 con- 
trols the formation of filopodia (Kozma et al., 1995; Nobes 
and Hall, 1995).  However, the relationship between these 
three small GTP-binding proteins and actin-based cellular 
events does not appear simple. For example, in KB and 
MDCK  cells,  membrane  ruffle  formation  is  reportedly 
regulated by Rho (Takaishi et al.,  1993; Nishiyama et al., 
1994), and the cleavage furrow formation is also Rho de- 
pendent in Xenopus and sea urchin eggs (Kishi et al., 1993; 
Mabuchi et al.,  1993).  The Rho-dependent enhancement 
of the CD44/ERM  complex formation would provide an 
increasing number of actin filament attachment  sites on 
the  cytoplasmic surface of plasma  membranes  at micro- 
villi,  cleavage furrows, ruffling membranes, and cell-cell/ 
cell-matrix adhesion sites. This speculation could explain the 
diversified functions of Rho in the regulation mechanism 
of actin filament/plasma membrane interaction in general. 
The Elevation of 4,5-PIP  2 Level in Plasma Membranes 
Is Possibly Involved in the Rho-dependent Regulation of 
the CD44/ERM Complex Formation 
The question then arises as to how Rho regulates the for- 
mation of the CD44/ERM complex in vivo. One explana- 
tion is that Rho directly regulates CD44/ERM association. 
This possibility was not considered likely. An alternative is 
that through one or several Rho downstream components, 
this complex formation is Rho dependent. Several inten- 
sive studies have been performed to identify the direct tar- 
get of Rho.  However, the list of activities stimulated by 
Rho as well as Rac and Cdc42 is long, and includes cas- 
cades of kinases that regulate gene transcription and cell 
growth, none of which have been linked to the actin fila- 
ment/plasma membrane interactions (Zigmond, 1995; Wa- 
tanabe et al.,  1996; Amano et al., 1996).  Rho reportedly 
regulates PI turnover (Chong et al., 1994; Divecha and Ir- 
vine, 1995; Zhang et al., 1995).  Furthermore, considering 
that Rac also rearranges the actin filaments also through 
4,5-PIP2 synthesis (Hartwig et al.,  1995), Rho might con- 
trol  actin-based  cellular  events  by  similar  mechanisms. 
The enzymatic activities of phosphatidylinositol 3-kinase 
(Zhang  et  al.,  1993),  phosphatidylinositol  4-phosphate 
5-kinase (Chong et al., 1994), and phospholipase D  (Bow- 
man et al., 1993; Malcolm et al., 1994) are reportedly regu- 
lated by Rho. Among them, the activation of phosphati- 
dylinositol  4-phosphate  5-kinase  elevates  the  4,5-PIPz 
concentration in membranes. 
At least as one of the signaling pathways that links Rho 
to the actin-based cytoskeleton, we speculate the follow- 
ing.  (a)  Activation of Rho directly or indirectly upregu- 
lates PIP5-kinase. (b) Activated PIP 5-kinase elevates the 
4,5-PIP2 level in plasma membranes. (c) The CD44/ERM 
complex formation is  induced by 4,5-PIP2.  The elevated 
4,5-PIP2 level in the plasma membranes could be derived 
from mechanisms other than PIP 5-kinase activation. Re- 
gardless, considering that lovastatin, a general inhibitor of 
small  GTP-binding proteins, suppresses  the  elevation of 
4,5-PIPz in the plasma membrane in vivo (Chong et al., 
1994), Rho is a likely upstream regulator of this elevation. 
Rho  also  reportedly  regulates  the  activity  of  some 
serine/threonine kinases  (Zigmond,  1995;  Amano  et  al., 
1996;  Watanabe  et  al.,  1996).  ERM  proteins  are  highly 
serine/threonine  phosphorylated  (Gould  et  al.,  1986; 
Urushidani et al., 1989; Nakamura et al.,  1995), and their 
phosphorylation is suggested to be involved in the regula- 
tion  of  the  ERM/membrane  association  (Chen  et  al., 
1995). We should examine the possibility that Rho regulates 
the ERM/membrane association through the serine/threo- 
nine phosphorylation of ERM proteins. The in vitro bind- 
ing system developed in this study would be useful for this 
purpose. Further molecular studies on how active Rho fa- 
cilitates the formation of CD44/ERM complex in vivo and 
how actin filament association with plasma membranes is 
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underway in our laboratory. 
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